{"organizations": [], "uuid": "365855550918f4f5d02d845a26df93e5186bedb0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-iovance-biotherapeutics-reports-q4/brief-iovance-biotherapeutics-reports-q4-non-gaap-loss-per-share-0-32-idUSASC09RUA", "country": "US", "domain_rank": 408, "title": "BRIEF-Iovance Biotherapeutics Reports Q4 Non-Gaap Loss Per Share $0.32", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-12T22:04:00.000+02:00", "replies_count": 0, "uuid": "365855550918f4f5d02d845a26df93e5186bedb0"}, "author": "", "url": "https://www.reuters.com/article/brief-iovance-biotherapeutics-reports-q4/brief-iovance-biotherapeutics-reports-q4-non-gaap-loss-per-share-0-32-idUSASC09RUA", "ord_in_thread": 0, "title": "BRIEF-Iovance Biotherapeutics Reports Q4 Non-Gaap Loss Per Share $0.32", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-iovance biotherapeutics", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "iovance biotherapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 12, 2018 / 8:05 PM / Updated 7 minutes ago BRIEF-Iovance Biotherapeutics Reports Q4 Non-Gaap Loss Per Share $0.32 Reuters Staff March 12 (Reuters) - Iovance Biotherapeutics Inc: * IOVANCE BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE * Q4 NON-GAAP LOSS PER SHARE $0.32 * Q4 GAAP LOSS PER SHARE $0.36 * Q4 EARNINGS PER SHARE VIEW $-0.32 — THOMSON REUTERS I/B/E/S * Q4 EARNINGS PER SHARE VIEW $-0.32 — THOMSON REUTERS I/B/E/S * IOVANCE - ANTICIPATES CASH, CASH EQUIVALENTS AND INVESTMENTS TO BE BETWEEN $190 MILLION AND $210 MILLION AT DECEMBER 31 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-03-12T22:04:00.000+02:00", "crawled": "2018-03-12T22:17:36.022+02:00", "highlightTitle": ""}